Harmonic Pharma has developed a unique Pharmacological Rediscovery© platform based on polypharmacology that consists in identifying the ensemble of biological targets linked to safe drugs in order to investigate their novel therapeutic applications. The company most advanced candidate HPH112 – developed in collaboration with Institut Curie – represents a promising drug candidate for a fast and de-risked clinical development in combination with the most recent treatments e.g. immunotherapy.